v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 6 Months Ended 83 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (3,197,923) $ (1,511,876) $ (49,431,157)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 431,849 154,365 3,031,087
Stock issued in connection with license agreements 0 0 6,613,718
Stock issued in connection with consulting agreement 0 0 158,262
Amortization of deferred financing costs 166,122 0 2,290,635
Amortization of debt discount 883,641 0 6,142,154
Warrants issued in connection with license agreement 76,574 0 76,574
Non-cash charge for beneficial conversion feature 0 0 1,137,762
Non-cash interest expense 0 0 3,007,018
Expenses paid on behalf of the Company satisfied through the issuance of notes 0 0 51,253
Depreciation 1,086 3,511 58,128
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 26,198 439,763 (15,700)
Security deposits 0 0 (13,342)
Accounts payable 387,430 (14,726) 1,285,180
Accrued expenses and accrued interest 50,420 (146,291) 328,578
Deferred rent (2,463) (1,144) 9,722
Net cash used in operating activities (1,177,066) (1,076,398) (25,270,128)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchase of equipment 0 0 (61,709)
Net cash used in investing activities 0 0 (61,709)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from notes payable to related parties 0 0 3,063,484
Proceeds from senior convertible notes 0 0 13,963,838
Proceeds from Galenica, Ltd. promissory note 0 0 1,000,000
Proceeds from exercise of warrants 60,000 0 60,000
Payments for deferred financing costs (60,000) (15,000) (1,577,603)
Repayment of amounts loaned under related party notes 0 0 (1,981,574)
Proceeds from sale of equity securities 533,000   10,990,270
Repurchase of outstanding warrants (33,000) 0 (33,000)
Proceeds from receipt of stock subscriptions and issuances of common stock 0 0 4,827
Net cash provided by (used in) financing activities 500,000 (15,000) 25,490,242
NET INCREASE (DECREASE) IN CASH (677,066) (1,091,398) 158,405
CASH - BEGINNING OF PERIOD 835,471 1,985,334  
CASH - END OF PERIOD 158,405 893,936 158,405
Cash paid for interest 56,728 0 75,153
Supplemental Disclosure of Non-Cash Financing Activities:      
Conversion of notes payable and accrued interest to common stock 457,000 0 19,354,167
Reclassification of deferred financing fees to additional paid-in capital 0 0 148,014
Stock issued to technology finders and licensors 0 0 155
Warrants issued to placement agent 0 0 854,608
Debt discount on senior convertible notes 0 0 6,312,768
Deemed dividend - beneficial conversion feature 309,944 0 309,944
Accrued deferred financing costs 52,292 0 83,095
Accrued private placement expenses $ 25,867 $ 0 $ 25,867